The indiscriminate use of antibiotics has increased exponentially and thus the ability of microbes to become resistant to such antibiotics. As a consequence, antibiotics become increasingly ineffective and ultimately completely useless for the treatment of infectious diseases.
The problem is even greater if we consider that in some antimicrobial categories there are few or no alternatives under development to replace non-effective antibiotics.
The growth in the number of resistant infections is reaching an alarming pace and infectious diseases already cause more than half a million deaths globally, and estimates indicate that if we don’t act soon, these numbers will reach 10 million deaths in 2050.
Fortunately, the scientific advances have unveiled several alternative products that are under development and that can be used for prevention and treatment of infectious diseases produced by resistant microbes.
These include phage therapy, lysins, antibodies, probiotics, peptides, vaccines and immune therapy in which DIOMUNE is already successfully generating immunomodulators capable of effectivelly fighting various infectious diseases in both humans and animals.